Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 731 shares at $2.70 ($1,975)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale CEO sold 5,394 shares at $2.02 ($10,894)
  6. 4 Planned sale SVP, Chief Financial Officer sold 474 shares at $2.02 ($957)
  7. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 749 shares at $2.02 ($1,513)
  8. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 713 shares at $2.15 ($1,535)
  9. 4 Planned sale CEO sold 5,603 shares at $2.15 ($12,064)
  10. 4 Planned sale SVP, Chief Financial Officer sold 461 shares at $2.15 ($993)
  11. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 710 shares at $2.60 ($1,843)
  12. 4 Planned sale SVP, Chief Financial Officer sold 458 shares at $2.60 ($1,189)
  13. 4 Planned sale CEO sold 5,592 shares at $2.60 ($14,517)
  14. 4 Planned sale SVP, Chief Financial Officer sold 679 shares at $2.58 ($1,752)
  15. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 5,121 shares at $2.49 ($12,757)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 18 · 351 filings